Maria Dranishnikova

Zacks spotlights cancer and sepsis test developer VolitionRx as undervalued

September 2, 2024

Value of company developing kidney disease treatments doubles in one day

August 30, 2024

Small caps and the U.S. election: How investors can win in the home stretch

August 29, 2024

Byrna shares rise after Uruguay buys its less-lethal launchers, ammunition

August 29, 2024

Pharmaceutical company Sonoma slides after reverse stock split announced

August 28, 2024

La Rosa Holdings shares advance after acquisition of competitor

August 28, 2024

Vaping addiction treatment developer changes CEO, possibly ahead of sale

August 27, 2024

Limestone manufacturer USLM slides after insider sale

August 27, 2024

Simply Wall St recommends three dividend stocks for investors seeking stability

August 27, 2024